Becker's Healthcare October 21, 2024
Alexandra Murphy

A total of $66.3 billion in outpatient drugs was purchased through the 340B drug pricing program in 2023, according to data from the Health Resources and Services Administration released Oct. 21.

The program allows safety-net providers to obtain discounted medications. Disproportionate share Hospitals accounted for the largest share of purchases, totaling $51.9 million. Other key...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Health System / Hospital, Pharma, Pharma / Biotech, Provider
Gene Therapy for Cardiomyopathies Presents Promising Alternative to Current Treatment
STAT+: 3 trends to watch in biotech in 2025
CVS, Walgreens & Walmart's healthcare strategy faces headwinds: 10 notes from 2024
The GLP-1 dilemma persists into 2025
The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender

Share This Article